N

NanoViricides
D

NNVC

1.50000
USD
0.02
(1.35%)
Market Closed
Volume
4,742
EPS
0
Div Yield
-
P/E
-2
Market Cap
21,520,500
Related Instruments
    A
    ALT
    0.09500
    (1.16%)
    8.27500 USD
    A
    AVIR
    0.07000
    (2.23%)
    3.20500 USD
    BNTX
    BNTX
    1.810
    (1.63%)
    113.050 USD
    I
    INO
    -0.01000
    (-0.54%)
    1.83000 USD
    MRNA
    MRNA
    -0.200
    (-0.51%)
    39.360 USD
    N
    NVAX
    0.05000
    (0.58%)
    8.72000 USD
    V
    VIR
    0.00000
    (0.00%)
    7.35000 USD
    V
    VXRT
    0.00480
    (0.79%)
    0.61260 USD
    More
News

Title: NanoViricides

Sector: Healthcare
Industry: Biotechnology
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in theapplication of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.